S'abonner

Medical error in dermatology practice: Development of a classification system to drive priority setting in patient safety efforts - 18/04/13

Doi : 10.1016/j.jaad.2012.10.058 
Alice J. Watson, MD, MPH a, , Kelley Redbord, MD b, c, d, James S. Taylor, MD e, Alison Shippy, MPH f, James Kostecki, MS f, Robert Swerlick, MD g
a Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 
b Private Practice in Rockville, Rockville, Maryland 
c Private Practice in Vienna, Vienna, Virginia 
d George Washington University, Washington, District of Columbia 
e Department of Dermatology, Cleveland Clinic, Cleveland, Ohio 
f American Academy of Dermatology, Washington, District of Columbia 
g Emory Medical School, Atlanta, Georgia 

Reprint requests: Alice J. Watson, MD, MPH, Department of Dermatology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.

Abstract

Background

To date, no study to our knowledge has examined the nature and scope of medical error in dermatology practice.

Objective

We sought to collect and categorize physician-reported errors in dermatology practice.

Methods

A survey regarding most recent and most serious errors was developed and distributed to dermatologists attending US meetings. A total of 150 responses were received outlining 152 most recent errors and 130 most serious errors. Survey responses, along with classification systems for other specialties, were used to develop a classification system for medical error in dermatology.

Results

The respondents’ demographics reflected the specialty: 63% were male, 60% were older than 50 years, and 60% were in solo or group private practice. Of the most recent errors reported, 85% happened once a year or less, and 86% did not result in harm to patients. The most common categories of both most recent and most serious errors were related to assessment (41% and 31%, respectively) and interventions (44% and 52%, respectively). Assessment errors were primarily related to investigations, and commonly involved the biopsy pathway. Intervention errors in the most recent and most serious errors were split between those related to medication (54% and 27%) and those related to procedures (46% and 73%). Of note, 5 and 21 wrong-site surgeries were reported in the most recent and most serious errors groups, respectively.

Limitations

Our findings are subject to respondent and recall bias and our classification system, although an important first step, is likely incomplete.

Conclusion

Our findings highlight several key areas of patient care in need of safety initiatives, namely the biopsy pathway, medication management, and prevention of wrong-site surgery.

Le texte complet de cet article est disponible en PDF.

Key words : medical error, patient safety, practice improvement, quality of care, Universal Protocol, wrong-site surgery


Plan


 This was a project of the Adverse Events Work Group of the Committee on Patient Safety and Quality of Care, American Academy of Dermatology; nominal administrative costs.
 Conflicts of interest: None declared.


© 2012  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 68 - N° 5

P. 729-737 - mai 2013 Retour au numéro
Article précédent Article précédent
  • Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution
  • Yukiko Ushigome, Yoko Kano, Tadashi Ishida, Kazuhisa Hirahara, Tetsuo Shiohara
| Article suivant Article suivant
  • Pediatric access to dermatologists: Medicaid versus private insurance
  • Sofia B. Chaudhry, Eric S. Armbrecht, Yoon Shin, Sarah Matula, Charles Caffrey, Reena Varade, Lisa Jones, Elaine Siegfried

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.